Cargando…
Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease
Studies have reported that Parkinson's disease (PD) is associated with impairments on cognitive visual tasks. However, the effects of dopamine on cognitive vision remain equivocal. The purpose of this study was to examine performance on cognitive vision tasks in persons with PD and the effects...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380130/ https://www.ncbi.nlm.nih.gov/pubmed/32849191 http://dx.doi.org/10.3389/fneur.2020.00708 |
_version_ | 1783562794752278528 |
---|---|
author | Anderson, Stephen Stegemöller, Elizabeth L. |
author_facet | Anderson, Stephen Stegemöller, Elizabeth L. |
author_sort | Anderson, Stephen |
collection | PubMed |
description | Studies have reported that Parkinson's disease (PD) is associated with impairments on cognitive visual tasks. However, the effects of dopamine on cognitive vision remain equivocal. The purpose of this study was to examine performance on cognitive vision tasks in persons with PD and the effects of levodopa on these tasks. Fourteen individuals with PD and 14 age- and sex-matched healthy older adults completed the study. Participants with PD completed the visual tasks following a 12-h withdrawal of dopaminergic medication and again 1 h after taking 1.5 times their normal dose of levodopa. Healthy older adults completed the visual tasks twice using the same session format. Five complex visual tasks were completed, including line discrimination, object discrimination, facial discrimination, visual working memory, and object rotation. The Unified Parkinson's Disease Rating Scale was also collected off and on medication. Participants with PD performed significantly worse than the healthy older adults across all five visual tasks. There were no significant differences in performance between the off and on medication state in persons with PD. This finding indicates either that dopamine deficiency may not be responsible for cognitive visual impairments in PD or that cognitive visual impairments in PD might simply be the result of deficits in more basic visual processing. |
format | Online Article Text |
id | pubmed-7380130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73801302020-08-25 Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease Anderson, Stephen Stegemöller, Elizabeth L. Front Neurol Neurology Studies have reported that Parkinson's disease (PD) is associated with impairments on cognitive visual tasks. However, the effects of dopamine on cognitive vision remain equivocal. The purpose of this study was to examine performance on cognitive vision tasks in persons with PD and the effects of levodopa on these tasks. Fourteen individuals with PD and 14 age- and sex-matched healthy older adults completed the study. Participants with PD completed the visual tasks following a 12-h withdrawal of dopaminergic medication and again 1 h after taking 1.5 times their normal dose of levodopa. Healthy older adults completed the visual tasks twice using the same session format. Five complex visual tasks were completed, including line discrimination, object discrimination, facial discrimination, visual working memory, and object rotation. The Unified Parkinson's Disease Rating Scale was also collected off and on medication. Participants with PD performed significantly worse than the healthy older adults across all five visual tasks. There were no significant differences in performance between the off and on medication state in persons with PD. This finding indicates either that dopamine deficiency may not be responsible for cognitive visual impairments in PD or that cognitive visual impairments in PD might simply be the result of deficits in more basic visual processing. Frontiers Media S.A. 2020-07-17 /pmc/articles/PMC7380130/ /pubmed/32849191 http://dx.doi.org/10.3389/fneur.2020.00708 Text en Copyright © 2020 Anderson and Stegemöller. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Anderson, Stephen Stegemöller, Elizabeth L. Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title | Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title_full | Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title_fullStr | Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title_full_unstemmed | Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title_short | Effects of Levodopa on Impairments to High-Level Vision in Parkinson's Disease |
title_sort | effects of levodopa on impairments to high-level vision in parkinson's disease |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380130/ https://www.ncbi.nlm.nih.gov/pubmed/32849191 http://dx.doi.org/10.3389/fneur.2020.00708 |
work_keys_str_mv | AT andersonstephen effectsoflevodopaonimpairmentstohighlevelvisioninparkinsonsdisease AT stegemollerelizabethl effectsoflevodopaonimpairmentstohighlevelvisioninparkinsonsdisease |